Bei Hu

14PUBLICATIONS
89CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)HaematologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 02, 2025
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.

Lihua E Budde, Huilai Zhang, Won-Seog Kim

|Sep 25, 2025
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.

Carrie Thompson, Marek Trněný, Franck Morschhauser

|Jul 05, 2024
The American Society of Hematology Health Equity Compendium: examining health equity across the Blood journals.

Warren B Fingrut, James Troyer, Eddrika Russell

|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Rahul S Bhansali, Fredrik Ellin, Thomas Relander

Pageof 3